← Back to Screener
Universe Pharmaceuticals Inc. Class A Ordinary Shares (UPC)
Price$3.32
Favorite Metrics
Price vs S&P 500 (26W)-58.37%
Price vs S&P 500 (4W)31.34%
Market Capitalization$1.90M
All Metrics
Book Value / Share (Quarterly)$99.64
P/TBV (Annual)0.04x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-28.07%
Cash Flow / Share (Quarterly)$-9.58
Price vs S&P 500 (YTD)-15.42%
Gross Margin (TTM)35.28%
Net Profit Margin (TTM)-20.56%
EPS (TTM)$-10.13
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$-10.13
Revenue Growth (5Y)-11.68%
EPS (Annual)$-8.06
ROI (Annual)-5.62%
Gross Margin (Annual)35.28%
Net Profit Margin (5Y Avg)-2.90%
Cash / Share (Quarterly)$59.63
Revenue Growth QoQ (YoY)-28.96%
ROA (Last FY)-5.30%
Revenue Growth TTM (YoY)-22.32%
EBITD / Share (TTM)$-6.55
ROE (5Y Avg)-9.77%
Operating Margin (TTM)-19.02%
Cash Flow / Share (Annual)$-9.58
P/B Ratio0.03x
P/B Ratio (Quarterly)0.04x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)-1.26x
Net Interest Coverage (TTM)-20.99x
ROA (TTM)-4.90%
EPS Incl Extra (Annual)$-8.06
Current Ratio (Annual)4.07x
Quick Ratio (Quarterly)3.63x
3-Month Avg Trading Volume0.05M
52-Week Price Return-7.65%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$99.11
P/S Ratio (Annual)0.11x
Asset Turnover (Annual)0.26x
52-Week High$11.00
Operating Margin (5Y Avg)2.37%
EPS Excl Extra (Annual)$-8.06
CapEx CAGR (5Y)47.34%
26-Week Price Return-49.63%
Quick Ratio (Annual)3.63x
13-Week Price Return-19.31%
Total Debt / Equity (Annual)0.16x
Current Ratio (Quarterly)4.07x
Enterprise Value$-22.431
Revenue / Share Growth (5Y)32.77%
Asset Turnover (TTM)0.24x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)5.88x
Pretax Margin (Annual)-20.56%
Cash / Share (Annual)$59.63
3-Month Return Std Dev90.85%
Gross Margin (5Y Avg)44.09%
Net Income / Employee (TTM)$-0
ROE (Last FY)-6.54%
Net Interest Coverage (Annual)-20.99x
EPS Basic Excl Extra (Annual)$-8.06
P/FCF (TTM)0.40x
Receivables Turnover (TTM)1.38x
Total Debt / Equity (Quarterly)0.16x
EPS Incl Extra (TTM)$-10.13
Receivables Turnover (Annual)1.38x
ROI (TTM)-5.72%
P/S Ratio (TTM)0.11x
Pretax Margin (5Y Avg)1.52%
Revenue / Share (Annual)$39.17
Tangible BV / Share (Annual)$99.11
Price vs S&P 500 (52W)-42.75%
Year-to-Date Return-11.29%
5-Day Price Return7.99%
EPS Normalized (Annual)$-8.06
ROA (5Y Avg)-6.49%
Net Profit Margin (Annual)-20.56%
Month-to-Date Return22.91%
Cash Flow / Share (TTM)$-2.26
EBITD / Share (Annual)$-6.76
Operating Margin (Annual)-19.02%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-7.99%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-10.13
P/TBV (Quarterly)0.04x
P/B Ratio (Annual)0.04x
Inventory Turnover (TTM)5.88x
Pretax Margin (TTM)-20.56%
Book Value / Share (Annual)$99.64
Price vs S&P 500 (13W)-22.18%
Beta1.64x
P/FCF (Annual)1.78x
Revenue / Share (TTM)$31.67
ROE (TTM)-6.60%
52-Week Low$2.00
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
UPCUniverse Pharmaceuticals Inc. Class A Ordinary Shares | 0.11x | -22.32% | 35.28% | — | $3.32 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Universe Pharmaceuticals Inc manufactures and distributes traditional Chinese medicine derivatives, biomedical drugs, medical instruments, and dietary supplements, with primary focus on chronic condition treatments and wellness products for elderly populations. The company's portfolio addresses age-related health conditions and longevity, supplemented by over-the-counter cold and flu medications.